ImmunityBio
6.05
+0.41
+7.27%
IBRX
02-06 16:00:00(美东时间)
高
6.08
开
5.70
量
1825.61万股
总市值
59.59亿
低
5.61
换
1.85%
额
1.07亿
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
ImmunityBio(IBRX)
01-26 20:05
$ImmunityBio(IBRX)$
8-K Current report, items 1.01 and 9.01 Accession Number: 0001326110-26-000014 Act: 34 Size: 173 KB
网页链接
ImmunityBio(IBRX)
01-22 09:45
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001647994-26-000002 Size: 426 KB
网页链接
ImmunityBio(IBRX)
01-22 09:35
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001849739-26-000002 Size: 433 KB
网页链接
ImmunityBio(IBRX)
01-21 05:35
$ImmunityBio(IBRX)$
144 Report of proposed sale of securities Accession Number: 0001950047-26-000561 Act: 33 Size: 5 KB
网页链接
ImmunityBio(IBRX)
01-21 00:15
$ImmunityBio(IBRX)$
144 Report of proposed sale of securities Accession Number: 0001949846-26-000009 Act: 33 Size: 4 KB
网页链接
ImmunityBio(IBRX)
01-17 05:25
$ImmunityBio(IBRX)$
144 Report of proposed sale of securities Accession Number: 0001950047-26-000516 Act: 33 Size: 5 KB
网页链接
ImmunityBio(IBRX)
01-15 21:45
$ImmunityBio(IBRX)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-26-000008 Act: 34 Size: 218 KB
网页链接
ImmunityBio(IBRX)
01-14 21:45
$ImmunityBio(IBRX)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001326110-26-000004 Act: 34 Size: 296 KB
网页链接
ImmunityBio(IBRX)
01-06 07:15
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001830328-26-000001 Size: 426 KB
网页链接
ImmunityBio(IBRX)
01-06 07:15
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001848899-26-000001 Size: 426 KB
网页链接
ImmunityBio(IBRX)
2025-12-29 19:05
$ImmunityBio(IBRX)$
8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-25-331244 Act: 34 Size: 188 KB
网页链接
ImmunityBio(IBRX)
2025-12-29 19:05
$ImmunityBio(IBRX)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-331242 Act: 33 Size: 735 KB
网页链接
ImmunityBio(IBRX)
2025-12-17 07:05
$ImmunityBio(IBRX)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001364846-25-000006 Size: 401 KB
网页链接
ImmunityBio(IBRX)
2025-12-17 07:05
$ImmunityBio(IBRX)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001364846-25-000007 Size: 6 KB
网页链接
ImmunityBio(IBRX)
2025-12-16 05:55
$ImmunityBio(IBRX)$
8-K Current report, items 5.02 and 9.01 Accession Number: 0001326110-25-000146 Act: 34 Size: 150 KB
网页链接
ImmunityBio(IBRX)
2025-12-12 20:05
$ImmunityBio(IBRX)$
8-K Current report, items 8.01 and 9.01 Accession Number: 0001326110-25-000143 Act: 34 Size: 219 KB
网页链接
ImmunityBio(IBRX)
2025-11-11 08:45
$ImmunityBio(IBRX)$
SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-274843 Act: 34 Size: 21 KB
网页链接
ImmunityBio(IBRX)
2025-11-05 19:15
$ImmunityBio(IBRX)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001326110-25-000138 Act: 34 Size: 297 KB
网页链接
ImmunityBio(IBRX)
2025-11-05 19:15
$ImmunityBio(IBRX)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001326110-25-000139 Act: 34 Size: 16 MB
网页链接
ImmunityBio(IBRX)
2025-10-21 05:35
$ImmunityBio(IBRX)$
DEF 14C Other definitive information statements Accession Number: 0001326110-25-000129 Act: 34 Size: 175 KB
网页链接